Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF-3 in experimental influenza A infection
NCT02423577Phase 2Completed
- Sponsor
- Autoimmune Technologies LLC
- Start
- Sep 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of flufirvitide in influenza, sponsored by Autoimmune Technologies LLC. Started Sep 2015; status: completed.
02
Drugs
flufirvitide
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02423577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02423577.